Literature DB >> 12791096

Egg yolk anti-BfpA antibodies as a tool for recognizing and identifying enteropathogenic Escherichia coli.

C M C de Almeida1, V M Quintana-Flores, E Medina-Acosta, A Schriefer, M Barral-Netto, W Dias da Silva.   

Abstract

Enteropathogenic Escherichia coli (EPEC) is a major aetiological agent of childhood diarrhoea in developing countries. The structural repeating protein A subunit, BfpA, found in the bundle-forming pilus, is one of the virulent factors for EPEC pathogenesis. Recombinant BfpA in laying hens elicited sustained and vigorous antibody production. Immunoglobulin Y (IgY) anti-BfpA antibodies were recovered from egg yolk, purified and characterized. Immunoadsorption with whole extracts of the isogenic E. coli EPEC adherence factor (EAF) strain that lacks BfpA rendered the resulting IgY preparations capable of: (a) recognizing purified or recombinant BfpA proteins in a dose-dependent fashion; (b) blocking the colonization of HeLa cells by EPEC EAF+, in vitro; (c) specifically identifying E. coli bearing EAF+; and (d) inhibiting the growth of E. coli EAF+ but not the EAF strain. IgY anti-BfpA is potentially useful as a specific, low-cost immunobiological reagent to screen human faecal specimens for the presence of EPEC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791096     DOI: 10.1046/j.1365-3083.2003.01243.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  In vitro inhibition of oral Candida albicans by chicken egg yolk antibody (IgY).

Authors:  X Z Wang; B Fan; L G Liu; X Y Hu; R Y Li; Y Wei; Z Wan; X L Deng
Journal:  Mycopathologia       Date:  2008-03-14       Impact factor: 2.574

2.  In vitro reactivity and growth inhibition of EPEC serotype O111 and STEC serotypes O111 and O157 by homologous and heterologous chicken egg yolk antibody.

Authors:  José Araujo Amaral; Milene Tino De Franco; Lucy Zapata-Quintanilla; Solange Barros Carbonare
Journal:  Vet Res Commun       Date:  2007-12-11       Impact factor: 2.459

3.  Growth inhibition of Staphylococcus aureus and escherichia coli strains by neutralizing IgY antibodies from ostrich egg yolk.

Authors:  Fernando Luiz Tobias; Luize Néli Nunes Garcia; Milton Masahiko Kanashiro; Enrique Medina-Acosta; João Gato Brom-de-Luna; Claudia Maria Costa de Almeida; Romildo Rocha Azevedo Junior; Môsar Lemos; Olney Vieira-da-Motta
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

Review 4.  IgY: a promising antibody for use in immunodiagnostic and in immunotherapy.

Authors:  Wilmar Dias da Silva; Denise V Tambourgi
Journal:  Vet Immunol Immunopathol       Date:  2010-01-07       Impact factor: 2.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.